Capital International Investors lifted its stake in shares of Core Laboratories N.V. (NYSE:CLB) by 0.3% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 412,711 shares of the oil and gas company’s stock after acquiring an additional 1,095 shares during the quarter. Capital International Investors owned about 0.94% of Core Laboratories N.V. worth $41,795,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Parallel Advisors LLC increased its stake in shares of Core Laboratories N.V. by 33.4% during the first quarter. Parallel Advisors LLC now owns 891 shares of the oil and gas company’s stock valued at $101,000 after acquiring an additional 223 shares during the period. Quantbot Technologies LP acquired a new position in shares of Core Laboratories N.V. during the first quarter valued at approximately $106,000. FNY Managed Accounts LLC acquired a new position in shares of Core Laboratories N.V. during the first quarter valued at approximately $123,000. Shine Investment Advisory Services Inc. acquired a new position in shares of Core Laboratories N.V. during the second quarter valued at approximately $134,000. Finally, First Bank & Trust increased its stake in shares of Core Laboratories N.V. by 5.8% during the second quarter. First Bank & Trust now owns 1,493 shares of the oil and gas company’s stock valued at $152,000 after acquiring an additional 82 shares during the period.

A number of research analysts recently commented on CLB shares. Royal Bank Of Canada set a $145.00 price objective on shares of Core Laboratories N.V. and gave the company a “buy” rating in a research note on Saturday, June 17th. ValuEngine upgraded shares of Core Laboratories N.V. from a “sell” rating to a “hold” rating in a research note on Friday, August 4th. BidaskClub upgraded shares of Core Laboratories N.V. from a “sell” rating to a “hold” rating in a research note on Tuesday, June 13th. Piper Jaffray Companies set a $97.00 price objective on shares of Core Laboratories N.V. and gave the company a “hold” rating in a research note on Wednesday, July 26th. Finally, Cowen and Company reiterated a “hold” rating and set a $100.00 price objective on shares of Core Laboratories N.V. in a research note on Friday, September 1st. Four investment analysts have rated the stock with a sell rating, eight have given a hold rating and five have given a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $113.36.

TRADEMARK VIOLATION NOTICE: This article was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The original version of this article can be viewed at https://www.thecerbatgem.com/2017/10/05/capital-international-investors-has-41-80-million-holdings-in-core-laboratories-n-v-clb.html.

Core Laboratories N.V. (CLB) traded down 0.07% during trading on Thursday, reaching $95.98. 27,362 shares of the company were exchanged. The firm has a market cap of $4.24 billion, a price-to-earnings ratio of 58.88 and a beta of 1.64. The firm has a 50-day moving average of $93.23 and a 200-day moving average of $102.92. Core Laboratories N.V. has a 52-week low of $86.55 and a 52-week high of $125.83.

Core Laboratories N.V. (NYSE:CLB) last issued its earnings results on Monday, July 24th. The oil and gas company reported $0.52 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.51 by $0.01. Core Laboratories N.V. had a net margin of 11.80% and a return on equity of 49.29%. The firm had revenue of $163.90 million during the quarter, compared to the consensus estimate of $168.23 million. During the same quarter in the prior year, the firm earned $0.35 earnings per share. The business’s quarterly revenue was up 10.7% on a year-over-year basis. On average, equities analysts forecast that Core Laboratories N.V. will post $1.99 EPS for the current year.

Core Laboratories N.V. Company Profile

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories N.V. (NYSE:CLB).

Institutional Ownership by Quarter for Core Laboratories N.V. (NYSE:CLB)

Receive News & Stock Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related stocks with our FREE daily email newsletter.